Business
SS Innovations and Dr. Frederic Moll to Deliver Keynote Presentation at the MoneyShow Investment Masters Symposium, Las Vegas
Dr. Moll, known as the ‘father of robotic surgery’, is the founder of Intuitive Surgical and creator of the da Vinci surgical system. FORT LAUDERDALE, FL,
About this update from Ss Innovations International Inc.
[{"type":"text","content":" Dr. Moll, known as the ‘father of robotic surgery’, is the founder of Intuitive Surgical and creator of the da Vinci surgical system. FORT LAUDERDALE, FL, Aug. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that it will present at the MoneyShow Investment Masters Symposium Las Vegas, held from August 8-10, 2023 at the Paris Las Vegas resort. Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, and a pioneer in robotic cardiothoracic surgery, will deliver a keynote presentation with Dr. Frederic Moll, the founder of Intuitive Surgical, the global leader in minimally invasive robotic surgery. The joint presentation will be titled: “SSII Is Shaping a New Era in Robotic Surgery,” and will be followed by a workshop session for conference attendees. Dr. Srivastava said, “We are very pleased to have the opportunity to showcase our flagship surgical robotic system, the SSi Mantra, at MoneyShow’s prestigious Investment Masters Symposium. I am delighted to join with Dr. Moll to highlight how SS Innovations is shaping the future of robotic surgery with our cost-effective, state of the art, surgical device. “This an exciting time for SS Innovations, as we prepare to pursue FDA and CE regulatory approvals for our SSi Mantra surgical robotic device.” The SSi Mantra is the first surgical system to be made in India, and one of the only systems in the world to be distinctly cost-effective with broad-spectrum surgical applications, including cardiovascular, thoracic, head and neck, gynecology, urology and general surgery. The device has been granted regulatory approval in India and is clinically validated in more than 40 different types of surgical procedures. SS Innovations anticipates receiving regulatory approvals for the SSi Mantra in the United States and Europe in 2024 and 2025. About SS Innovations International, Inc.SS Innovations International, Inc. (OTC: SSII) is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger part of the global population. SSII’s product range...